Home » Healthcare » South Africa Single-Use Bio-Processing Systems Market

South Africa Single-Use Bio-Processing Systems Market

South Africa Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Contract Manufacturing Organizations (CMOs), Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
South Africa Single-Use Bio-Processing Systems Market Size 2024	USD 70.83 million
South Africa Single-Use Bio-Processing Systems Market, CAGR	12.97%
South Africa Single-Use Bio-Processing Systems Market Size 2032	USD 187.86 million

Market Overview

South Africa Single-Use Bio-Processing Systems market size was valued at USD 70.83 million in 2024 and is anticipated to reach USD 187.86 million by 2032, at a CAGR of 12.97% during the forecast period (2024-2032).

The South Africa Single-Use Bio-Processing Systems market is primarily driven by the increasing demand for cost-effective and flexible biomanufacturing solutions. The adoption of single-use technologies offers significant advantages, such as reduced risk of contamination, lower capital investments, and quicker turnaround times compared to traditional multi-use systems. As the biopharmaceutical industry expands, particularly in the production of biologics and vaccines, the need for scalable, efficient, and flexible manufacturing processes grows. Additionally, the push for more sustainable production practices further boosts the demand for single-use systems, as they reduce the need for extensive cleaning and sterilization. Trends such as advancements in disposable bioreactor systems, improved automation, and integration with digital technologies also contribute to the market’s growth, enhancing operational efficiency and reducing human error. These factors are expected to drive significant growth in the South African market over the forecast period.

Geographically, the South Africa Single-Use Bio-Processing Systems market is primarily concentrated in key regions such as Gauteng, Western Cape, KwaZulu-Natal, and Eastern Cape. Gauteng, as the economic and industrial hub, leads the market due to its high concentration of biopharmaceutical manufacturing and R&D facilities. Western Cape follows with its strong emphasis on biotechnology and pharmaceutical innovation, while KwaZulu-Natal is gaining momentum due to its strategic location and expanding pharmaceutical industry. Eastern Cape, though currently smaller in market presence, holds future potential as the bio-manufacturing sector grows. Key players in the market include leading global and local companies such as Aspen Pharmacare Holdings Limited, Biovac Institute, Thermo Fisher Scientific, Merck KGaA, Sartorius, Danaher, Lonza, Getinge AB, Mabion SA, and Afrigen Biologics. These players are driving innovation and adoption of single-use bio-processing technologies to meet the growing demand for biologics and vaccines in the region.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The South Africa Single-Use Bio-Processing Systems market was valued at USD 70.83 million in 2024 and is expected to reach USD 187.86 million by 2032, growing at a CAGR of 12.97% during the forecast period.

The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.
The demand for single-use systems is driven by the need for cost-effective, flexible, and scalable solutions in the biopharmaceutical manufacturing process.

AI and ML integration, adoption by CMOs, and advancements in material science are key trends enhancing market growth.
Competitive landscape includes companies like Aspen Pharmacare, Thermo Fisher Scientific, Merck KGaA, and Sartorius, focusing on innovation and market expansion.
The market faces challenges such as high initial capital investment and reliance on international suppliers for single-use components.
Gauteng and Western Cape dominate the market due to high biopharmaceutical activity, with growing opportunities in KwaZulu-Natal and Eastern Cape.
Regulatory developments and the evolving landscape in South Africa provide a favorable environment for single-use system adoption.

Report Scope

This report segments the South Africa Single-Use Bio-Processing Systems Market as follows:

Market Drivers

Cost Efficiency and Flexibility in Biomanufacturing

The primary driver of the South Africa Single-Use Bio-Processing Systems market is the demand for cost-effective and flexible manufacturing solutions in the biopharmaceutical sector. Traditional stainless steel bioreactors require substantial upfront capital investment and incur high operational costs due to cleaning, sterilization, and maintenance procedures. For instance, a report from BioPlan Associates highlights that single-use bioprocessing systems reduce operational downtime and offer significant cost benefits by eliminating cleaning and sterilization expenses. In contrast, single-use systems offer a more affordable alternative, reducing the need for large-scale facilities and the associated ongoing maintenance costs. Furthermore, these systems provide manufacturers with the flexibility to scale production up or down as needed, making them ideal for both small batch production and large-scale commercial manufacturing. This flexibility is crucial for the growing number of biotechnology startups and contract manufacturers in South Africa, helping them remain competitive while reducing financial risks.

Technological Advancements and Sustainability Focus

Advancements in single-use bioprocessing technology are a key factor contributing to the market’s growth. Innovations in disposable bioreactor systems, filtration devices, and other processing components are making these systems more efficient, reliable, and suitable for a broader range of applications. For instance, Thermo Fisher Scientific has developed single-use bioprocessing solutions optimized for sustainability, reducing water and energy consumption. Additionally, the integration of automation, digital tools, and real-time monitoring into single-use systems enhances operational efficiency and minimizes human error. Moreover, there is a growing emphasis on sustainability within the biopharmaceutical industry, and single-use systems are seen as more environmentally friendly. The reduced need for extensive cleaning, sterilization, and water consumption is in line with the industry’s broader efforts to minimize its environmental footprint. These technological advancements and sustainability considerations are encouraging more biopharma companies in South Africa to adopt single-use systems, thus driving the market’s growth.

Increased Demand for Biologics and Vaccines

The rising global demand for biologics, including monoclonal antibodies, cell and gene therapies, and vaccines, is a significant driver for the South African market. Single-use bio-processing systems are particularly well-suited for the production of biologics, which require specialized manufacturing processes that can be quickly adjusted to meet changing demands. In the context of vaccine production, such as during pandemics or outbreaks, the ability to rapidly scale up production is crucial. Single-use systems enable faster turnaround times and a more efficient ramp-up in manufacturing capacity compared to traditional systems. This aligns well with South Africa’s growing focus on self-sufficiency in vaccine production and other biologic medicines, driving the need for adaptable and scalable production systems.

Focus on Reducing Contamination Risks

The South African biopharmaceutical industry increasingly recognizes the importance of minimizing contamination risks in drug production. Single-use systems provide a significant advantage over traditional multi-use systems by reducing the potential for cross-contamination between batches, which is a critical concern in biologics manufacturing. These systems are designed to be used once and then discarded, eliminating the need for labor-intensive cleaning and sterilization processes. As a result, the risk of introducing microbial contaminants or host-cell proteins is minimized, ensuring higher quality and purity of final products. This focus on contamination control aligns with global regulatory standards and quality assurance protocols, further driving the adoption of single-use technologies within the South African market.

Market Trends

Integration of Artificial Intelligence and Machine Learning

The integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies into single-use bio-processing systems is a major trend driving innovation in South Africa’s biomanufacturing sector. AI and ML are revolutionizing the industry by enabling real-time data monitoring, predictive analytics, and process optimization. For instance, the South African Department of Science and Innovation has launched AI-driven initiatives to enhance automation and efficiency in biomanufacturing. These technologies provide biopharmaceutical manufacturers with the tools to enhance operational efficiency, predict equipment failure, optimize production parameters, and reduce human errors. AI-driven analytics allow for the identification of potential process deviations and the adjustment of variables in real time, ensuring consistent product quality. In addition, AI and ML algorithms can improve the scalability of bioprocesses by predicting optimal conditions for large-scale production, which is essential in a growing market like South Africa’s. As these technologies continue to advance, they are expected to play a significant role in enhancing the performance and reliability of single-use bio-processing systems, improving both production efficiency and cost-effectiveness.

Regulatory Developments and Standardization

As the adoption of single-use bio-processing technologies grows, the South African government and regulatory bodies are placing greater emphasis on developing and enforcing standards to ensure the safety and efficacy of biopharmaceutical products. Regulatory frameworks are evolving to address the specific needs of single-use systems and ensure that these technologies meet stringent quality control and safety regulations. For instance, South Africa’s Department of Science and Innovation is working on biotechnology regulatory frameworks to align with international standards. In South Africa, collaborations between regulatory authorities and industry stakeholders are fostering the development of guidelines and best practices for the use of single-use systems in biomanufacturing. These regulatory updates are not only helping to streamline the approval processes for new products but are also building confidence in the quality and safety of single-use systems. This supportive regulatory environment is essential for further growth in the market as it helps align South Africa with international standards, making it an attractive destination for global pharmaceutical companies and ensuring the safe production of high-quality biologics and vaccines.

Adoption by Contract Manufacturing Organizations (CMOs)

Contract Manufacturing Organizations (CMOs) in South Africa are increasingly adopting single-use bio-processing systems to enhance their service offerings to biopharmaceutical clients. Single-use systems are highly attractive to CMOs due to their ability to provide flexible, cost-efficient, and scalable solutions. CMOs benefit from these systems by being able to produce different types of biopharmaceuticals without the need for significant capital investment in traditional, multi-use facilities. The reduced maintenance costs associated with single-use systems, as well as the ability to rapidly change production configurations, make these systems an ideal choice for contract manufacturers serving a diverse range of clients. As biopharmaceutical companies look to outsource manufacturing to specialized CMOs, the demand for single-use technologies continues to rise. CMOs in South Africa are tapping into this growing market, leveraging the flexibility and reduced operational costs that single-use bio-processing systems offer, thereby contributing to the market’s expansion in the region.

Advancements in Material Science

Material science plays a crucial role in the development and performance of single-use bio-processing systems. In South Africa, advancements in material science are driving the improvement of single-use systems’ efficiency, safety, and overall performance. Manufacturers are continuously refining the materials used in bio-processing components, such as bioreactors, filtration units, and connectors, to ensure better durability, reduced extractables and leachables, and improved biocompatibility. These advancements are particularly important for ensuring that single-use systems do not introduce contaminants into the biopharmaceutical production process, which could compromise the safety and efficacy of the final product. In addition, innovations in material science are also addressing issues related to temperature stability, mechanical strength, and scalability. As a result, these improved materials are making single-use systems more reliable and versatile, further driving their adoption in South Africa’s growing biomanufacturing sector.

Market Challenges Analysis

High Initial Capital Investment

One of the key challenges facing the South Africa Single-Use Bio-Processing Systems market is the high initial capital investment required for the adoption of these technologies. While single-use systems offer long-term cost savings, such as reduced maintenance and cleaning costs, the upfront investment for equipment and materials can be substantial, particularly for smaller biopharmaceutical companies and contract manufacturing organizations (CMOs) in South Africa. Additionally, the ongoing need to purchase disposable components for each batch can create challenges in terms of cost predictability and supply chain management. Smaller players in the market may find it difficult to absorb these costs, which can limit the widespread adoption of single-use technologies. For many companies, this financial barrier remains a significant challenge, slowing the rate at which single-use systems are adopted across the sector.

Limited Local Supplier Network

Another challenge is the relatively limited local supplier network for single-use bio-processing components and systems in South Africa. While the demand for these systems is growing, there is a dependency on global suppliers for many critical components, such as disposable bioreactors, filters, and connectors. For instance, the South African Department of Trade, Industry, and Competition has highlighted that the country’s reliance on imported biomanufacturing components limits the ability of local firms to negotiate favorable pricing and supply terms. This reliance on international suppliers can lead to longer lead times, higher shipping costs, and potential supply chain disruptions, particularly during global crises like the COVID-19 pandemic. Moreover, the lack of a robust local manufacturing base for single-use components can contribute to price volatility and limit the ability of South African companies to negotiate favorable terms with suppliers. As the market continues to grow, expanding the local supplier network and developing regional manufacturing capabilities will be crucial in addressing these challenges and ensuring the availability and affordability of single-use systems for South African biopharmaceutical companies.

Market Opportunities

The South Africa Single-Use Bio-Processing Systems market presents significant opportunities driven by the expanding biopharmaceutical sector and the increasing demand for flexible, cost-efficient production methods. As the local biopharma industry grows, particularly in the production of biologics, vaccines, and advanced therapies, there is a notable shift towards adopting single-use systems to enhance scalability, reduce operational costs, and improve turnaround times. This is especially relevant for Contract Manufacturing Organizations (CMOs) in South Africa, which can leverage single-use technologies to offer flexible and rapid production services without large upfront capital investments. The cost-effectiveness, ease of use, and faster regulatory approval times associated with single-use systems position them as an attractive option for companies seeking to scale production quickly in response to rising demand, creating ample opportunities for market expansion in the coming years.

Additionally, there is considerable potential for South African companies to develop and expand their local supplier networks for single-use bio-processing components. By fostering partnerships with global manufacturers or investing in domestic production capabilities, local companies can reduce reliance on international suppliers, ensuring a more reliable supply chain and greater cost stability. As regulatory frameworks continue to evolve and become more favorable towards single-use systems, there is an opportunity for South Africa to position itself as a key player in the global bio-manufacturing ecosystem. Furthermore, with growing emphasis on sustainability in the biopharma sector, single-use systems’ reduced environmental impact compared to traditional multi-use systems presents an opportunity to align with global sustainability trends. By capitalizing on these opportunities, South Africa can strengthen its position in the bio-manufacturing market and attract investment from international players.

Market Segmentation Analysis:

By Type:

The South Africa Single-Use Bio-Processing Systems market is categorized into several key types, including single-use bioreactors, mixers, bags, connectors, and others. Among these, single-use bioreactors are the dominant segment due to their widespread application in cell culture and fermentation processes, crucial for the production of biologics, vaccines, and other biologic drugs. These bioreactors offer flexibility, scalability, and reduced contamination risks, making them ideal for both small-scale and large-scale production. Single-use mixers and bags are also gaining significant traction as they facilitate smooth mixing and storage of biological materials, reducing the risk of contamination and minimizing the need for cleaning between production cycles. Single-use connectors are another essential component, enabling efficient, sterile fluid transfer in bioprocessing systems, which is vital for maintaining the integrity of biopharmaceutical products. The “Others” category includes disposable filters, sensors, and other specialized equipment used in bio-processing, all contributing to the flexibility and efficiency of biomanufacturing in South Africa.

By Application:

The South Africa Single-Use Bio-Processing Systems market can also be analyzed based on application, with key segments including research and development (R&D), manufacturing, process development, commercial production, and others. R&D plays a crucial role in advancing biopharmaceutical innovations, and single-use systems are increasingly being adopted in this space due to their adaptability and ease of use in small-scale experiments. In manufacturing and process development, single-use technologies provide cost-effective, scalable, and efficient solutions, reducing the need for large, expensive stainless-steel equipment. Commercial production is a growing segment as biopharmaceutical companies look to scale their operations with flexibility and reduced contamination risks, a key benefit of single-use systems. The “Others” category includes applications in cell and gene therapies, which are emerging areas in biopharmaceutical production. As the market continues to evolve, demand across these application segments is expected to increase, contributing to overall growth in the South African single-use bio-processing market.

Segments:

Based on Type:

Single-Use Bioreactors
Single-Use Mixers
Single-Use Bags
Single-Use Connectors
Others

Based on Application:

Research & Development
Manufacturing
Process Development
Commercial Production
Others

Based on End- User:

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Contract Manufacturing Organizations (CMOs)
Others

Based on the Geography:

Gauteng
Western Cape
KwaZulu-Natal
Eastern Cape

Regional Analysis

Gauteng

Gauteng, which includes major urban centers like Johannesburg and Pretoria, holds the largest market share in the region, accounting for approximately 45% of the market. This dominance is due to Gauteng’s status as the economic and industrial hub of South Africa, home to a significant portion of the country’s biopharmaceutical manufacturing facilities, research and development centers, and contract manufacturing organizations (CMOs). The concentration of these activities, along with a well-established infrastructure, positions Gauteng as the leader in the adoption of single-use bio-processing technologies.

Western Cape

Western Cape follows with a market share of around 30%, driven by the strong presence of biopharma research institutions and innovation hubs in cities like Cape Town. The region is known for its growing biotechnological research and development activities, with several global and local pharmaceutical companies setting up operations. As a result, the demand for flexible and cost-efficient bio-processing solutions, such as single-use systems, is steadily increasing. Western Cape’s focus on scientific innovation and high-quality production facilities further strengthens its position as a key player in South Africa’s bio-manufacturing sector.

KwaZulu-Natal

KwaZulu-Natal, contributing approximately 15% to the market, is emerging as a significant region for single-use bio-processing adoption. The province is home to several pharmaceutical manufacturing facilities and is strategically located with ports that facilitate international trade, making it an attractive location for bio-manufacturers looking to expand their global reach. As the province continues to develop its biopharmaceutical industry, the demand for flexible, scalable, and contamination-free production systems like single-use bioreactors and mixers is expected to grow, further increasing its market share.

Eastern Cape

Eastern Cape, with a smaller market share of around 10%, is gradually emerging as a developing region in the bio-processing industry. While it currently lags behind the more industrialized provinces, it is witnessing growth in pharmaceutical manufacturing and associated infrastructure. The demand for single-use systems is expected to rise as more companies set up operations in the region, capitalizing on cost-effective, scalable bio-manufacturing solutions to meet increasing demand. Although it holds a smaller portion of the market today, Eastern Cape presents untapped potential for future growth in the coming years as the biopharmaceutical industry expands across South Africa.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Aspen Pharmacare Holdings Limited
Biovac Institute
Thermo Fisher Scientific Middle East
Merck KGaA Middle East
Sartorius Middle East
Danaher Middle East
Lonza Middle East
Getinge AB Middle East
Mabion SA
Afrigen Biologics

Competitive Analysis

The competitive landscape of the South Africa Single-Use Bio-Processing Systems market is shaped by both local and international players offering a diverse range of solutions. Leading players in the market include Aspen Pharmacare Holdings Limited, Biovac Institute, Thermo Fisher Scientific, Merck KGaA, Sartorius, Danaher, Lonza, Getinge AB, Mabion SA, and Afrigen Biologics. These companies are focused on expanding their product portfolios, driving innovation, and meeting the growing demand for biologics and vaccines. Companies in this space focus on enhancing their product portfolios with single-use bioreactors, mixers, bags, connectors, and other components that cater to the biopharmaceutical manufacturing industry. The increasing demand for biologics and vaccines in South Africa drives the need for flexible and scalable bio-processing technologies. Competition is fierce as companies leverage advancements in artificial intelligence (AI), machine learning (ML), and material science to enhance product efficiency, reduce contamination risks, and improve operational scalability. Many players are also capitalizing on the growing trend of contract manufacturing, which relies heavily on single-use systems for their flexibility and low operational costs. Additionally, these companies focus on regulatory compliance and providing customized solutions that meet local industry standards, enabling them to differentiate themselves in a competitive market. Strategic partnerships, collaborations, and technological advancements are central to staying competitive, as the demand for single-use systems is expected to grow significantly in the coming years. With the region’s expanding biopharmaceutical industry, players are positioning themselves to take advantage of the opportunities presented by the increasing adoption of single-use technologies.

Recent Developments

In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The South Africa Single-Use Bio-Processing Systems market exhibits a moderate level of concentration, with several key players, both local and international, dominating the landscape. While the market is still evolving, large global companies with a strong presence in the biopharmaceutical sector, such as Thermo Fisher Scientific, Sartorius, and Merck KGaA, hold significant market share. However, local players, such as Aspen Pharmacare and Biovac Institute, are increasing their influence by catering to the unique demands of the South African market, particularly in the vaccine and biologics production space. The market is characterized by a growing demand for cost-effective, scalable, and flexible solutions, which single-use technologies provide. With the rising adoption of biopharmaceutical manufacturing in South Africa, there is increasing competition for market share, leading to continuous innovations and strategic partnerships. As a result, the market is dynamic, with a mix of well-established global players and emerging local competitors contributing to its growth.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The South Africa Single-Use Bio-Processing Systems market is expected to experience steady growth driven by the increasing demand for biologics and vaccines.
Advancements in AI and machine learning will continue to enhance operational efficiency, process optimization, and real-time monitoring in bio-manufacturing.
Local manufacturing and R&D investments will help reduce dependency on international suppliers, improving supply chain resilience.
Increased adoption of single-use technologies by contract manufacturing organizations (CMOs) will contribute to market expansion.
The regulatory environment in South Africa is expected to evolve, fostering further growth and standardization of single-use bio-processing systems.
Growing focus on sustainability will drive the development of environmentally friendly single-use systems, aligning with global trends.
Regional markets such as KwaZulu-Natal and Eastern Cape will present new opportunities for growth as bio-manufacturing expands beyond traditional hubs.
The rise of personalized medicine and gene therapies will increase the demand for flexible and scalable bio-processing solutions.
The market will see increased competition, with both global and local players focusing on innovation and cost-efficiency.
Collaboration between biopharma companies and single-use system providers will accelerate the adoption of advanced, customized bio-processing solutions in the region.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. South Africa Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by South Africa 31

5.1.1. South Africa Single-Use Bio-Processing Systems Market Import Volume/Revenue, By South Africa, 2018 – 2023 31

5.2. Export Analysis by South Africa 32

5.2.1. South Africa Single-Use Bio-Processing Systems Market Export Volume/Revenue, By South Africa, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by South Africa 33

6.1.1. South Africa Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By South Africa, 2018 – 2023 33

6.2. Supply Analysis by South Africa 34

6.2.1. South Africa Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By South Africa, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by South Africa 35

7.1.1. South Africa Single-Use Bio-Processing Systems Market Production Volume/Revenue, By South Africa, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. South Africa Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. South Africa Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. South Africa Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. South Africa Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. South Africa Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. South Africa Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. South Africa Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. South Africa Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

South Africa Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – SOUTH AFRICA ANALYSIS 76

16.1. Type 76

16.1.1. South Africa Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. South Africa Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. South Africa Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. South Africa Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. South Africa Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. South Africa Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

CHAPTER NO. 17 : COMPANY PROFILES 79

17.1. Aspen Pharmacare Holdings Limited 79

17.1.1. Company Overview 79

17.1.2. Product Portfolio 79

17.1.3. Swot Analysis 79

17.1.4. Business Strategy 80

17.1.5. Financial Overview 80

17.2. Biovac Institute 81

17.3. Thermo Fisher Scientific Middle East 81

17.4. Merck KGaA Middle East 81

17.5. Sartorius Middle East 81

17.6. Danaher Middle East 81

17.7. Lonza Middle East 81

17.8. Getinge AB Middle East 81

17.9. Mabion SA 81

17.10. Afrigen Biologics 81

List of Figures

FIG NO. 1. South Africa Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for South Africa Single-Use Bio-Processing Systems Market 29

FIG NO. 3. South Africa Single-Use Bio-Processing Systems Market Import Volume/Revenue, By South Africa, 2018 – 2023 31

FIG NO. 4. South Africa Single-Use Bio-Processing Systems Market Export Volume/Revenue, By South Africa, 2018 – 2023 32

FIG NO. 5. South Africa Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By South Africa, 2018 – 2023 33

FIG NO. 6. South Africa Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By South Africa, 2018 – 2023 34

FIG NO. 7. South Africa Single-Use Bio-Processing Systems Market Production Volume/Revenue, By South Africa, 2018 – 2023 35

FIG NO. 8. South Africa Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for South Africa Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. South Africa Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. South Africa Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. South Africa Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. South Africa Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. South Africa Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. South Africa Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. South Africa Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. South Africa Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. South Africa Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. South Africa Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. South Africa Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. South Africa Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. South Africa Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. South Africa Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. South Africa Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : South Africa Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : South Africa Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : South Africa Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : South Africa Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : South Africa Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : South Africa Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : South Africa Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : South Africa Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

Frequently Asked Questions

What is the current size of the South Africa Single-Use Bio-Processing Systems market?

The market was valued at USD 70.83 million in 2024 and is projected to reach USD 187.86 million by 2032, growing at a CAGR of 12.97%.

What factors are driving the growth of the South Africa Single-Use Bio-Processing Systems market?

Growth is driven by rising demand for biologics and vaccines, cost-efficient manufacturing, and increased adoption by CMOs and biotech startups.

What are some challenges faced by the South Africa Single-Use Bio-Processing Systems market?

Major challenges include high initial capital investment and dependency on international suppliers for single-use components.

Who are the major players in the South Africa Single-Use Bio-Processing Systems market?

Key players include Aspen Pharmacare, Biovac Institute, Thermo Fisher Scientific, Merck KGaA, Sartorius, and Afrigen Biologics.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –